Continuous autonomic assessment in patients with symptomatic heart failure: Prognostic value of heart rate variability measured by an implanted cardiac resynchronization device

Circulation

Volumn 110, Issue 16, 2004, Pages 2389-2394

  Adamson, Philip B ^a,e   Smith, Andrew L ^b   Abraham, William T ^c   Kleckner, Karen J ^d   Stadler, Robert W ^d   Shih, Alex ^d   Rhodes, Melissa M ^d  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d MEDTRONIC INC   (United States)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Heart failure; Heart rate; Mortality; Nervous system, autonomic; Trials

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; AUTONOMIC INNERVATION; FEMALE; HEART ATRIUM; HEART FAILURE; HEART FUNCTION TEST; HEART RATE; HEART RATE VARIABILITY; HOSPITALIZATION; HUMAN; IMPLANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NIGHT; NIGHT HEART RATE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SYMPTOMATOLOGY;

AGED; ALGORITHMS; AUTONOMIC NERVOUS SYSTEM; CIRCADIAN RHYTHM; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HEART RATE; HOSPITALIZATION; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MONITORING, PHYSIOLOGIC; MOTOR ACTIVITY; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 6444228048     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000139841.42454.78     Document Type: Article

References (20)

1. Rich MW, Beekham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190-1195.
2. Fonarow G, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30:725-732.
3. Hanumanthu S, Butler J, Chomsky D, et al. Effect of a heart failure program on hospitalization frequency and exercise tolerance. Circulation. 1997;96:2842-2848.
4. Adamson PB, Kleckner K, VanHout WL, et al. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation. 2003;108:266-269.
5. Adamson PB, Magalski A, Braunschweig F, et al. Ongoing right ventricular hemodynamics heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 2003;41:563-567.
6. Kleiger RE, Miller JP, Bigger JT Jr, et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256-262.
7. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93:1043-1065.
8. La Rovere MT, Pinna GD, Maestri R, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107:565-570.
9. La Rovere MT, Pinna GD, Hohnloser SH, et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001;103:2072-2077.
10. Bigger JT, Fleiss JL, Rolnitzky LM, et al. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation. 1993;88:927-934.
11. Abraham WT, Fisher WG, Smith AL, et al, for the MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845-1853.
12. Malik M, Camm AJ. Components of heart rate variability: what they really mean and what we really measure. Am J Cardiol. 1993;72:821-822.
13. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-254.
14. Cohn JN. The management of chronic heart failure. N Engl J Med. 1996;335:490-498.
15. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
16. Cohn JN. Sympathetic nervous system in heart failure. Circulation. 2002;106:2417-2418.
17. Cohn JN, Pfeffer MA, Rouleau J, et al. Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON). Eur J Heart Fail. 2003;5:659-667.
18. Adamson PB, Vanoli E. Early autonomic and repolarization abnormalities contribute to lethal arrhythmias in chronic ischemic heart failure: characteristics of a novel heart failure model in dogs with postmyocardial infarction left ventricular dysfunction. J Am Coll Cardiol. 2001;37:1741-1748.
19. Taylor JA, Carr DL, Myers CW, et al. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation. 1998;98:547-555.
20. Moller M, Nielsen BL, Fabricius J. Paroxysmal ventricular tachycardia during repeated 24-hour ambulatory electrocardiographic monitoring of postmyocardial infarction patients. Br Heart J. 1980;43:447-453.